|
1 |
A Comprehensive Whole-Body Physiologically Based Pharmacokinetic Drug–Drug–Gene Interaction Model of Metformin and Cimetidine in Healthy Adults and Renally Impaired Individuals
Enthalten in Clinical pharmacokinetics 25.5.2020: 1-13
|
|
|
|
2 |
Comprehensive Parent–Metabolite PBPK/PD Modeling Insights into Nicotine Replacement Therapy Strategies
Enthalten in Clinical pharmacokinetics 12.3.2020: 1-16
|
|
|
|
3 |
Effective Removal of Dabigatran by Idarucizumab or Hemodialysis: A Physiologically Based Pharmacokinetic Modeling Analysis
Enthalten in Clinical pharmacokinetics 4.2.2020: 1-17
|
|
|
|
4 |
Physiologically Based Pharmacokinetic Models for Prediction of Complex CYP2C8 and OATP1B1 (SLCO1B1) Drug–Drug–Gene Interactions: A Modeling Network of Gemfibrozil, Repaglinide, Pioglitazone, Rifampicin, Clarithromycin and Itraconazole
Enthalten in Clinical pharmacokinetics 25.5.2019: 1-13
|
|
|
|
5 |
A Novel Approach for Quantifying the Pharmacological Activity of T-Cell Engagers Utilizing In Vitro Time Course Experiments and Streamlined Data Analysis
Enthalten in American Association of Pharmaceutical Scientists: The AAPS journal Bd. 24, 3.12.2021, Nr. 1, date:2.2022: 1-13
|
|
|
|
6 |
Effect of an interprofessional care concept on the hospitalization of nursing home residents: study protocol for a cluster-randomized controlled trial
Enthalten in Trials Bd. 21, 18.5.2020, Nr. 1, date:12.2020: 1-11
|
|
|
|
7 |
Physiologically Based Pharmacokinetic Models of Probenecid and Furosemide to Predict Transporter Mediated Drug-Drug Interactions
Enthalten in Pharmaceutical research Bd. 37, 25.11.2020, Nr. 12, date:12.2020: 1-14
|
|
Administration
